Department of Otolaryngology - Head and Neck Surgery, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Department of Otolaryngology, Head and Neck Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjuku, Tokyo 160-8582, Japan.
Dis Model Mech. 2021 Nov 1;14(11). doi: 10.1242/dmm.049015. Epub 2021 Nov 26.
KCNQ4 encodes the homotetrameric voltage-dependent potassium ion channel Kv7.4, and is the causative gene for autosomal dominant nonsyndromic sensorineural hearing loss, DFNA2. Dominant-negative inhibition accounts for the observed dominant inheritance of many DFNA2-associated KCNQ4 variants. In addition, haploinsufficiency has been presumed as the pathological mechanism for truncated Kv7.4 variants lacking the C-terminal tetramerization region, as they are unlikely to exert a dominant-negative inhibitory effect. Such truncated Kv7.4 variants should result in relatively mild hearing loss when heterozygous; however, this is not always the case. In this study, we characterized Kv7.4Q71fs (c.211delC), Kv7.4W242X (c.725G>A) and Kv7.4A349fs (c.1044_1051del8) in heterologous expression systems and found that expression of these truncated Kv7.4 variants induced cell death. We also found similar cell death-inducing cytotoxic effects in truncated Kv7.1 (KCNQ1) variants, suggesting that the generality of our findings could account for the dominant inheritance of many, if not most, truncated Kv7 variants. Moreover, we found that the application of autophagy inducers can ameliorate the cytotoxicity, providing a novel insight for the development of alternative therapeutic strategies for Kv7.4 variants.
KCNQ4 编码同源四聚体电压依赖性钾离子通道 Kv7.4,是常染色体显性非综合征性感觉神经性听力损失(DFNA2)的致病基因。显性负抑制解释了许多与 DFNA2 相关的 KCNQ4 变体观察到的显性遗传。此外,由于缺乏 C 末端四聚化区域的截断 Kv7.4 变体不太可能产生显性负抑制作用,因此假定杂合不足是其病理机制。当这些截断的 Kv7.4 变体为杂合子时,它们应该导致相对温和的听力损失;然而,情况并非总是如此。在这项研究中,我们在异源表达系统中对 Kv7.4Q71fs(c.211delC)、Kv7.4W242X(c.725G>A)和 Kv7.4A349fs(c.1044_1051del8)进行了表征,发现这些截断的 Kv7.4 变体的表达会诱导细胞死亡。我们还发现截断的 Kv7.1(KCNQ1)变体也具有类似的诱导细胞死亡的细胞毒性作用,这表明我们的发现的普遍性可以解释许多,如果不是大多数,截断 Kv7 变体的显性遗传。此外,我们发现自噬诱导剂的应用可以改善细胞毒性,为 Kv7.4 变体的替代治疗策略的发展提供了新的思路。